| Amgen (AMGN) |
United States |
$149.676B |
15.65 |
| Bristol Myers Squibb (BMY) |
United States |
$146.690B |
10.46 |
| CSL (CSLLY) |
Australia |
$97.146B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$85.440B |
11.36 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$62.750B |
29.18 |
| Illumina (ILMN) |
United States |
$61.466B |
84.54 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$58.496B |
20.75 |
| Moderna (MRNA) |
United States |
$58.169B |
0.00 |
| Biogen (BIIB) |
United States |
$42.401B |
7.53 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$35.304B |
14.06 |
| BeiGene (BGNE) |
Cayman Islands |
$34.370B |
0.00 |
| Seagen (SGEN) |
United States |
$32.583B |
85.77 |
| Genmab (GMAB) |
Denmark |
$27.988B |
33.10 |
| Genmab (GNMSF) |
Denmark |
$26.645B |
6.14 |
| BioNTech SE (BNTX) |
Germany |
$25.027B |
0.00 |
| Exact Sciences (EXAS) |
United States |
$23.155B |
0.00 |
| Incyte (INCY) |
United States |
$22.009B |
0.00 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$20.412B |
0.00 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$18.788B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$17.603B |
66.75 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$17.328B |
24.77 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$16.151B |
107.19 |
| Guardant Health (GH) |
United States |
$15.726B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$14.928B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$13.607B |
87.02 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$12.906B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$12.264B |
27.61 |
| Repligen (RGEN) |
United States |
$11.328B |
160.66 |
| Mirati Therapeutics (MRTX) |
United States |
$10.710B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$9.777B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$9.045B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$8.960B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$8.959B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$8.577B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$8.487B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$8.388B |
0.00 |
| Novavax (NVAX) |
United States |
$8.369B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$7.585B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$7.584B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$7.282B |
0.00 |
| Exelixis (EXEL) |
United States |
$7.080B |
47.54 |
| Halozyme Therapeutics (HALO) |
United States |
$6.597B |
305.00 |
| NeoGenomics (NEO) |
United States |
$6.319B |
1897.00 |
| Beam Therapeutics (BEAM) |
United States |
$5.942B |
0.00 |
| SWEDISH ORP BIO (BIOVF) |
Sweden |
$5.829B |
17.04 |
| Blueprint Medicines (BPMC) |
United States |
$5.735B |
18.99 |
| Vir Biotechnology (VIR) |
United States |
$5.655B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$5.638B |
18.50 |
| Certara (CERT) |
United States |
$5.630B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$5.326B |
0.00 |
| Eidos Therapeutics (EIDX) |
United States |
$4.751B |
0.00 |
| China Biologic Products (CBPO) |
China |
$4.660B |
30.20 |
| Arena Pharmaceuticals (ARNA) |
United States |
$4.537B |
0.00 |
| Insmed (INSM) |
United States |
$4.468B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$4.218B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$4.104B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$3.997B |
0.00 |
| Arvinas (ARVN) |
United States |
$3.995B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$3.919B |
141.86 |
| Legend Biotech (LEGN) |
United States |
$3.676B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$3.640B |
35.73 |
| Bluebird Bio (BLUE) |
United States |
$3.193B |
0.00 |
| I-Mab (IMAB) |
China |
$3.022B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$2.987B |
0.00 |
| Amarin (AMRN) |
Ireland |
$2.956B |
0.00 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$2.737B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$2.719B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.509B |
65.00 |
| Arcus Biosciences (RCUS) |
United States |
$2.479B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$2.440B |
0.00 |
| ADC Therapeutics SA (ADCT) |
Switzerland |
$2.346B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$2.267B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$2.217B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$2.129B |
0.00 |
| NantKwest (NK) |
United States |
$2.064B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$2.057B |
17.02 |
| Scholar Rock Holding (SRRK) |
United States |
$2.041B |
0.00 |
| Viela Bio (VIE) |
United States |
$2.011B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$1.997B |
0.00 |
| Vericel (VCEL) |
United States |
$1.982B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$1.982B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.936B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$1.928B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$1.927B |
0.00 |
| Genetron Holdings (GTH) |
China |
$1.891B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.880B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$1.816B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.769B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
United States |
$1.701B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.683B |
0.00 |
| Precigen (PGEN) |
United States |
$1.651B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$1.643B |
0.00 |
| Heska (HSKA) |
United States |
$1.580B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$1.528B |
0.00 |
| Codexis (CDXS) |
United States |
$1.487B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$1.475B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.458B |
0.00 |
| Alector (ALEC) |
United States |
$1.438B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.409B |
9.31 |
| Travere Therapeutics (TVTX) |
United States |
$1.387B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$1.372B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.343B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$1.342B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$1.330B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$1.276B |
0.00 |
| Athenex (ATNX) |
United States |
$1.250B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.221B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$1.193B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$1.146B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$1.093B |
0.00 |
| Mesoblast (MESO) |
Australia |
$1.079B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$1.026B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$1.022B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$1.006B |
0.00 |
| Morphic Holding (MORF) |
United States |
$0.982B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.979B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$0.967B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.952B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.904B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.901B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.890B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.885B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.879B |
23.42 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.874B |
0.00 |
| MannKind (MNKD) |
United States |
$0.872B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.866B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.834B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.784B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.780B |
39.63 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.780B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.748B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.745B |
0.00 |
| Agenus (AGEN) |
United States |
$0.742B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.722B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.698B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.697B |
0.00 |
| ALBIREO PHARMA (ALBO) |
United States |
$0.694B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.687B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.681B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.677B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.640B |
35.94 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.639B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.612B |
0.00 |
| Curis (CRIS) |
United States |
$0.604B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.601B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.599B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.595B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.582B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.579B |
0.00 |
| Aquinox Pharmaceuticals (NLTX) |
United States |
$0.571B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.559B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.550B |
74.40 |
| Prothena (PRTA) |
Ireland |
$0.550B |
0.00 |
| Geron (GERN) |
United States |
$0.546B |
0.00 |
| Pandion Therapeutics (PAND) |
United States |
$0.533B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.515B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.500B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.499B |
0.00 |
| FORTE BIOSCIENC (FBRX) |
United States |
$0.493B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.477B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.468B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.467B |
0.00 |
| Amryt Pharma (AMYT) |
United Kingdom |
$0.466B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.465B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.462B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.453B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.451B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.437B |
0.00 |
| XOMA (XOMA) |
United States |
$0.437B |
0.00 |
| Athersys (ATHX) |
United States |
$0.425B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.425B |
20.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.398B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.397B |
10.11 |
| Lineage Cell Therapeutics (LCTX) |
United States |
$0.388B |
0.00 |
| NextCure (NXTC) |
United States |
$0.375B |
0.00 |
| Trevena (TRVN) |
United States |
$0.367B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.366B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.366B |
0.00 |
| Verastem (VSTM) |
United States |
$0.363B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.353B |
0.00 |
| AMMO (POWW) |
United States |
$0.345B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.340B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.333B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.330B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.328B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.326B |
8.36 |
| IBio (IBIO) |
United States |
$0.311B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.309B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.303B |
14.19 |
| ChromaDex (CDXC) |
United States |
$0.302B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.292B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.289B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.282B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.277B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.273B |
0.00 |
| Cerecor (CERC) |
United States |
$0.255B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.247B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.244B |
0.00 |
| VolitionRX (VNRX) |
United States |
$0.241B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.239B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.234B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.233B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.230B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.219B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.215B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$0.213B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.211B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.204B |
0.00 |
| Exicure (XCUR) |
United States |
$0.201B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.199B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.197B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.196B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.196B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.192B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.192B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.191B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.186B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.182B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.179B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.174B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.173B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.170B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.162B |
336.00 |
| Lumos Pharma (LUMO) |
United States |
$0.160B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.158B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.157B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.157B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.152B |
0.00 |
| Prometic Life Sciences (LMNL) |
Canada |
$0.151B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.151B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.149B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.148B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.146B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.142B |
0.00 |
| Seelos Therapeutics (SEEL) |
United States |
$0.142B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.139B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.139B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.129B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.127B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.126B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.125B |
0.00 |
| Ecology Coatings (ABVC) |
United States |
$0.123B |
0.00 |
| AIT Therapeutics (XAIR) |
United States |
$0.122B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.113B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.113B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.113B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.110B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.109B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.103B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.096B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.095B |
0.00 |
| Stealth BioTherapeutics (MITO) |
United States |
$0.094B |
44.75 |
| Windtree Therapeutics (WINT) |
United States |
$0.094B |
0.00 |
| Adocia (ADOCY) |
France |
$0.091B |
0.00 |
| CollPlant Holdings (CLGN) |
Israel |
$0.084B |
0.00 |
| CytRx (CYTR) |
United States |
$0.080B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.071B |
0.00 |
| ARIDIS PHARMACT (ARDS) |
United States |
$0.071B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.066B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.066B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.062B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.061B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.059B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.059B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.058B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.058B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.058B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.056B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.056B |
0.00 |
| Enveric Biosciences (ENVB) |
United States |
$0.056B |
0.00 |
| Appili Therapeutics (APLIF) |
Canada |
$0.054B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.054B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.053B |
0.00 |
| Yumanity Therapeutics (YMTX) |
United States |
$0.053B |
0.00 |
| Celsion (CLSN) |
United States |
$0.052B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.050B |
0.00 |
| Chanticleer Holdings (SONN) |
United States |
$0.049B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.044B |
0.00 |
| Spherix (AIKI) |
United States |
$0.043B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.042B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.042B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.042B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.040B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.036B |
0.00 |
| PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.029B |
0.00 |
| Neuralstem (SNCA) |
United States |
$0.028B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.023B |
0.00 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.023B |
0.00 |
| Cesca Therapeutics (THMO) |
United States |
$0.022B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.019B |
0.00 |
| Invo BioScience (INVO) |
United States |
$0.015B |
0.00 |
| BioPharmX (TMBR) |
United States |
$0.015B |
0.00 |
| CTD Holdings (CYTH) |
United States |
$0.011B |
0.00 |
| Benitec Biopharma (BNTC) |
United States |
$0.005B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
| Viridian Therapeutics (VRDN) |
United States |
$0.000B |
0.00 |
| Zai Lab (ZLAB) |
China |
$0.000B |
0.00 |
